Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	115,680	58,996	-	-
Enterprise Value	110,348	57,851	-	-
Last Close Price	1038.00	545.00	-	-
PS Ratio	39.40	25.47	-	-
PB Ratio	5.70	2.97	-	-
P/TBV Ratio	5.75	2.97	-	-
EV/Sales Ratio	37.58	24.98	-	-
Debt / Equity Ratio	0.39	0.37	0.39	0.06
Asset Turnover	-	0.12	0.13	-
Inventory Turnover	-	13.35	4.36	-
Quick Ratio	6.32	6.40	3.18	3.86
Current Ratio	6.52	7.29	3.97	4.14
Return on Equity (ROE)	-	-25.90%	-19.05%	-
Return on Assets (ROA)	-	-9.71%	-10.58%	-
Return on Capital (ROIC)	-	-10.08%	-11.51%	-
Earnings Yield	-3.59%	-6.09%	-	-
FCF Yield	-	-15.48%	-	-
Buyback Yield / Dilution	-	-13.79%	-4.04%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.